Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Alternatives · Fidelity

Fidelity SAI Merger Arbitrage Fund (FMADX)

Ticker FMADX · · Holdings as of Jul 31, 2026

Expense ratio
1.1%$110/yr per $10k
Net assets
$637.0Mall share classes
Holdings
35

Bottom line

Is FMADX a good fund? The bottom line

FMADX is an actively managed alternatives mutual fund from Fidelity.

Its expense ratio is 1.1% — about $110 a year on every $10,000 invested, cheaper than 72% of alternatives funds we track.

With $637 million in net assets and 35 holdings, its largest position is Mastercard Inc (15.0%) and the top 10 make up 76% of the portfolio.

What to watch

  • Concentrated: top 10 holdings are 76% of assets
  • High turnover (11% a year) can mean more taxable distributions

Updated Nov 19, 2026

What FMADX invests in

Fidelity SAI Merger Arbitrage Fund seeks capital appreciation.

"Employing a merger arbitrage strategy that seeks to generate returns from discrepancies in asset pricing before and after merger or reorganization events. Executing the fund's merger arbitrage strategy through investments in equity securities and equity related derivative instruments, including special purpose acquisition vehicles (""SPACs""), of companies that are or may be involved in publicly announced or reported merger or re-organization events (including pre-definitive and definitive takeovers, buyouts, liquidations, corporate simplifications, spin offs, and other similar corporate transactions and reorganizations), including stock-for-stock, cash, and mixed consideration mergers and acquisitions (""a Merger Transaction""), or companies that the Adviser believes may be involved in Merger Transactions. Utilizing other types of securities such as debt securities (including unrated…

From the fund's prospectus (filed Mar 27, 2026).

What FMADX costs

On a $10,000 investment, FMADX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,422 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.

See the full FMADX fee table →

FMADX top 10 holdings

#Holding% of fund
1Mastercard Inc15.02%
2Warner Bros Discovery Inc9.39%
3Kenvue Inc8.99%
4Ust Bills8.28%
5Electronic Arts Inc8.24%
6Nvidia Corp7.88%
7Apogee Therapeutics Inc4.99%
8Digitalbridge Group Inc4.70%
9Crinetics Pharmaceuticals Inc4.26%
10Bio Techne Corp4.25%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 76% of the fund. See all top 25 holdings and asset mix →

Alternatives to FMADX

More funds like FMADX →

FMADX FAQ

What is the expense ratio of FMADX?
FMADX's expense ratio is 1.1%, which works out to about $110 a year for every $10,000 invested. The prospectus estimates total costs of $1,422 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FMADX a good investment?
It depends on your goals, but the data points to: concentrated: top 10 holdings are 76% of assets; high turnover (11% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does FMADX hold?
FMADX's largest holdings are Mastercard Inc (15.0%), Warner Bros Discovery Inc (9.4%), Kenvue Inc (9.0%), Ust Bills (8.3%), Electronic Arts Inc (8.2%). It holds 35 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages FMADX?
FMADX is offered by Fidelity through Fidelity Greenwood Street Trust.